Q3 2022 Holdings
Filed 2022-11-09 | 17 holdings | $906.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Third Harmonic Bio, Inc.(THRD) | Common Stock | 88427A107 | $206.9K | 10,907,859 | 22.8% |
| Day One Biopharmaceuticals, Inc.(DAWN) | Common Stock | 23954D109 | $163.6K | 8,169,171 | 18.1% |
| Kymera Therapeutics, Inc.(KYMR) | Common Stock | 501575104 | $149.7K | 6,875,698 | 16.5% |
| Dyne Therapeutics, Inc.(DYN) | Common Stock | 26818M108 | $113.5K | 8,934,902 | 12.5% |
| Replimune Group, Inc.(REPL) | Common Stock | 76029N106 | $53.7K | 3,108,300 | 5.9% |
| Vigil Neuroscience, Inc.(VIGL) | Common Stock | 92673K108 | $53.1K | 5,836,874 | 5.9% |
| Generation Bio, Co.(GBIOGBX) | Common Stock | 37148K100 | $44.0K | 8,278,876 | 4.9% |
| Aerovate Therapeutics, Inc. | Common Stock | 008064107 | $38.6K | 2,327,909 | 4.3% |
| Akero Therapeutics, Inc.(AKRO) | Common Stock | 00973Y108 | $33.9K | 994,251 | 3.7% |
| Ikena Oncology, Inc. | Common Stock | 45175G108 | $17.8K | 5,018,178 | 2.0% |
| Gemini Therapeutics, Inc. | Common Stock | 36870G105 | $8.6K | 5,254,365 | 1.0% |
| Xilio Therapeutics, Inc.(XLO) | Common Stock | 98422T100 | $8.0K | 2,759,344 | 0.9% |
| Magenta Therapeutics, Inc. | Common Stock | 55910K108 | $4.9K | 3,476,536 | 0.5% |
| F-star Therapeutics, Inc. | Common Stock | 30315R107 | $3.1K | 599,524 | 0.3% |
| AvroBio, Inc. | Common Stock | 05455M100 | $2.9K | 4,520,863 | 0.3% |
| Spero Therapeutics, Inc.(SPRO) | Common Stock | 84833T103 | $2.1K | 1,031,160 | 0.2% |
| Viridian Therapeutics, Inc.(VRDN) | Common Stock | 92790C104 | $1.8K | 90,072 | 0.2% |